Literature DB >> 17949069

Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX.

Tiziano Tuccinardi1, Gabriella Ortore, Armando Rossello, Claudiu T Supuran, Adriano Martinelli.   

Abstract

Carbonic anhydrase (CA) IX is a very interesting subject for study due to its overexpression in cancer and its expression in very few normal tissues. There are not yet experimental 3D structures of the catalytic domain of this isozyme, and only a few computational studies have been reported. A homology model of CA IX was developed, and using Gold software 124 CA IX inhibitors were docked. The best poses of the ligands were then used as an alignment tool for the development of the first reported CA IX 3D-QSAR model. The obtained results confirm the reliability of the constructed CA IX model and the proposed computational strategy for investigating CAs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949069     DOI: 10.1021/ci700214j

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties.

Authors:  Andrea Angeli; Victor Kartsev; Anthi Petrou; Mariana Pinteala; Volodymyr Brovarets; Sergii Slyvchuk; Stepan Pilyo; Athina Geronikaki; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

2.  Homology modeling a fast tool for drug discovery: current perspectives.

Authors:  V K Vyas; R D Ukawala; M Ghate; C Chintha
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

3.  Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes.

Authors:  Petar Žuvela; J Jay Liu; Myunggi Yi; Paweł P Pomastowski; Gulyaim Sagandykova; Mariusz Belka; Jonathan David; Tomasz Bączek; Krzysztof Szafrański; Beata Żołnowska; Jarosław Sławiński; Claudiu T Supuran; Ming Wah Wong; Bogusław Buszewski
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.